The Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA) are supposed to meet to review a set of scientific issues regarding EPA’s evaluation of the carcinogenic potential of glyphosate, the active ingredient in Roundup and hundreds of other herbicides sold around the world.
The objective of the consultations is to determine how the EPA should interpret appropriate data and how this evidence should translate into a “carcinogen risk” classification for glyphosate. This may seem like a strictly academic task, but powerful economic forces are at work when it comes to glyphosate, the most widely-used agricultural chemical. You can move to www.monsantoroundupcancerlawsuit.com, if you have some queries regarding the cancer lawsuits and roundup cancer lawsuits.
If glyphosate is officially classified by the EPA as a carcinogen (cancer-causing substance), it could be devastating to Monsanto’s bottom line and even threaten its proposed $66 billion merger with Bayer AG. Monsanto is also facing dozens of lawsuits alleging cancer from Roundup, and the company is desperate for EPA backing to defend itself against the complaints.
The glyphosate / cancer link is not something new. Numerous scientific studies have raised concerns about the potential harmful effects of the chemical. Monsanto has always countered with its own studies and high-powered team of experts who claim that glyphosate is not carcinogenic, and in fact actually one of the safest pesticides ever brought to market.
The World Health Organization’s International Agency for Research on Cancer (IARC) published a report in The Lancet Oncology which declared that glyphosate “probably” causes cancer in humans.